Cassava Sciences, Inc. FLNA
0.75
(0.02)
(2.60%)
as of 25 Sep
- Market cap
- $37.8M
- P/E
- 0.0×
Follow FLNA
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (55.78%) | (79.59%) | (82.66%) | (85.44%) |
+8 more TTM periods Free account |
|
| (35.34%) | (62.50%) | (65.95%) | (59.99%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(66.33%) | (114.14%) | (122.08%) | (129.80%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.61) | (0.62) | (0.68) | (1.74) | |
Free Cash Flow |
(29.36) | (29.79) | (32.91) | (83.95) | |
Capital Expenditures |
(0.66) | — | (0.65) | (0.18) | |
| Other line items | |||||
Cash ROIC |
(19.62%) | (19.26%) | (18.98%) | (44.64%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.68 | 0.38 | 0.35 | 0.79 | |
Depreciation/Fixed assets |
0.05 | 0.05 | 0.05 | 0.04 | |
Capex/Depreciation |
(0.67) | 0.00 | (0.70) | (0.22) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.59) | (0.62) | (0.67) | (1.73) | |
Capex per Share |
(0.01) | 0.00 | (0.01) | 0.00 | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates